208 related articles for article (PubMed ID: 35380253)
1. Identification of promising CD8 and CD4 T cell epitopes for peptide vaccine formulation against SARS-CoV-2.
Chakraborty S; Deb B; Nath D; Monoswita D
Arch Microbiol; 2022 Apr; 204(5):242. PubMed ID: 35380253
[TBL] [Abstract][Full Text] [Related]
2. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
4. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
5. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
Singh J; Malik D; Raina A
Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
[TBL] [Abstract][Full Text] [Related]
6. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
8. Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
Lim HX; Lim J; Jazayeri SD; Poppema S; Poh CL
Biomed J; 2021 Mar; 44(1):18-30. PubMed ID: 33727051
[TBL] [Abstract][Full Text] [Related]
9. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
10. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
11. Immuno-informatics analysis predicts B and T cell consensus epitopes for designing peptide vaccine against SARS-CoV-2 with 99.82% global population coverage.
Shukla P; Pandey P; Prasad B; Robinson T; Purohit R; D'Cruz LG; Tambuwala MM; Mutreja A; Harkin J; Rai TS; Murray EK; Gibson DS; Bjourson AJ
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34962259
[TBL] [Abstract][Full Text] [Related]
12. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Almofti YA; Abd-Elrahman KA; Eltilib EEM
BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
[TBL] [Abstract][Full Text] [Related]
13. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
14. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
Akhtar N; Joshi A; Singh B; Kaushik V
Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
[TBL] [Abstract][Full Text] [Related]
15. Cross-protection induced by highly conserved human B, CD4
Prakash S; Dhanushkodi NR; Zayou L; Ibraim IC; Quadiri A; Coulon PG; Tifrea DF; Suzer B; Shaik AM; Chilukuri A; Edwards RA; Singer M; Vahed H; Nesburn AB; Kuppermann BD; Ulmer JB; Gil D; Jones TM; BenMohamed L
Front Immunol; 2024; 15():1328905. PubMed ID: 38318166
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
[TBL] [Abstract][Full Text] [Related]
17. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
18. Design of an epitope-based peptide vaccine against the SARS-CoV-2: a vaccine-informatics approach.
Alam A; Khan A; Imam N; Siddiqui MF; Waseem M; Malik MZ; Ishrat R
Brief Bioinform; 2021 Mar; 22(2):1309-1323. PubMed ID: 33285567
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
20. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine.
Shehata MM; Mahmoud SH; Tarek M; Al-Karmalawy AA; Mahmoud A; Mostafa A; M Elhefnawi M; Ali MA
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]